Purpose Covered, self-expandable metallic stents (SEMS) have been enthusiastically adopted for the treatment of esophagotracheal fistula, but problems with stent migration have yet to be resolved. To overcome this problem, we have developed a new hanging-type esophageal stent designed to prevent migration, and we conducted an animal study to assess the efficacy of our method. Methods A total of six female pigs were used in this study. The main characteristic of our stent was the presence of a string tied to the proximal edge of the stent for fixation under the skin of the neck. The first experiment was performed to confirm technical feasibility in three pigs with esophagotracheal fistula. The second experiment was performed to evaluate stent migration and esophagotracheal fistula in three pigs. Results Creation of the esophagotracheal fistula and stent placement were technically successful in all pigs. In the first experiment, esophagotracheal fistula was sealed by stent placement. In the second experiment, no stent migration was seen 11 or 12 days after stent placement. Gross findings showed no fistulas on the esophageal or tracheal wall. Conclusions Our new hanging-type esophageal stent seems to offer a feasible method for preventing stent migration.
Introduction
Esophagotracheal fistulas are occasionally seen as a complication of locally advanced tumor growth [1, 2] . Similarly, and with the same devastating consequences, fistulation may occur as a complication of anastomotic dehiscence after esophageal resection with or without preceding damage to the respiratory tract [3] [4] [5] .
Self-expandable metallic stents (SEMS) were introduced in the mid 1990s for the palliation of dysphagia resulting from incurable malignant esophageal strictures. Several papers in recent years have enthusiastically described the use of covered SEMS for the treatment of esophagorespiratory fistulas [1, [6] [7] [8] [9] [10] [11] . These studies showed excellent clinical improvement of symptoms, but the results actually ended up proving unsatisfactory. One of the major problems in the placement of SEMS for such fistulas is stent migration, the rate of which is likely to be higher in patients without strictures [12] .
To overcome this problem with stent migration, we have developed a new hanging-type esophageal stent for preventing migration, and we conducted an animal study to assess the potential of using this covered SEMS for closure of esophagotracheal fistulas.
Materials and Methods

Animals
Protocols for this animal study were approved by the institutional Animal Care and Use Committee. Handling and caring for laboratory animals in this study was performed according to institutional guidelines. A total of six female pigs weighing 35-43 (mean, 40) kg were used in this study. General anesthesia was induced by intramuscular injection of medetomidine at 80 lg/kg body weight and ketamine hydrochloride at 5 mg/kg body weight.
Animals were intubated and ventilated using a mixture of nitrous oxide, oxygen, and 1.5-3% sevoflurane.
Experiment 1: Technical Feasibility Study
The technical feasibility of our method was examined in the first experiment using three pigs. We used a handmade Z-stent woven from a single thread of 0.4-mm thick stainless wire with six bent points on the upper and lower end portions. The stent was fully covered with Dacron and was 60-mm long and 40 mm in diameter. A string was tied to the proximal edge of the stent for fixation under the skin of the neck on the opposite end to prevent migration (Fig. 1A) .
We created an esophagotracheal fistula before stent placement (Fig. 2) . A Rösch-Uchida Liver Access set (RUPS-100; Cook, Bloomington, IN), a 6-mm diameter balloon catheter (Wanda; Boston Scientific, Natick, MA), and a 0.035-inch guidewire (Radifocus; Terumo, Tokyo, Japan) were used to make the esophagotracheal fistula. All procedures were performed under fluoroscopic guidance. First, the guidewire was inserted into the esophagus through the mouth, and a 10-Fr catheter with a dilator was inserted until the distal tip was positioned above the bifurcation of the trachea. With the catheter left in place, the guidewire and dilator were removed. Next, a 14-gauge stiffening cannula was introduced through the catheter and its tip was turned toward the trachea. Confirming that the tip of the stiffening cannula pressed the trachea on anterior and lateral projections of x-ray fluoroscopy, the trachea was punctured from the esophagus through the mediastinum using a 0.038-inch trocar stylet with a 5-Fr catheter ( Fig. 2A) . After the puncture, the guidewire was introduced into the trachea and balloon catheter was inserted over the guidewire. The created tract was then dilated using the balloon catheter (Fig. 2B) . Finally, an esophagogram was obtained using nonionic contrast medium (Iopamiro 300; Nihon Schering, Osaka, Japan) to check the esophagotracheal fistula (Fig. 2C) . Immediately after creating the esophagotracheal fistula, stent placement was undertaken using handmade stent, a PTEG catheter kit (Sumitomo Bakelite, Tokyo, Japan) and a 25-mm diameter loop snare (Amplatz GooseNeck Snare Kit; ev3, Plymouth, MN; Fig. 3 ). First, a 0.035-inch guide wire was inserted into the esophagus through the mouth. A rupture-free balloon (RFB) was introduced into the esophagus over the guidewire and positioned at the level of the cervical esophagus. Next, the RFB was filled with nonionic contrast medium and punctured using a puncture needle by a percutaneous approach under fluoroscopic guidance (Fig. 3A) , followed by the introduction of the second guidewire into the esophageal lumen. The RFB and second guidewire were then advanced downward simultaneously into the distal esophagus (Fig. 3B ). After confirming that the guidewire was positioned in the esophageal lumen, the RFB was removed. After introducing a 6-Fr guiding catheter over the second guidewire, a snare wire was inserted into the esophageal lumen through the catheter. The first guidewire, which had been inserted through the mouth, was advanced downward into the distal esophagus through the snare (Fig. 3C) . A 25-Fr sheath with dilator was introduced over the guidewire through the mouth until its distal tip reached the thoracic esophagus. With the sheath left in place, the dilator and guidewire were removed. The handmade stent was compressed until it fit into the distal end of the sheath (Fig. 3D) . The stent was then advanced into the esophagus using a pusher catheter. The sheath was then withdrawn while the pusher catheter was held immobile. The stent was positioned and deployed to seal the created fistula (Fig. 3E) . The sheath and pusher catheter were withdrawn from the esophagus after stent deployment. We drew back the loop snare and pulled the string outside of the body and then sutured the string under the skin of the neck (Fig. 3F) . Postprocedural fluoroscopy was performed immediately after stent placement to verify the stent position. Esophagography also was performed to ensure that there was no leakage of nonionic contrast medium into the trachea. Three pigs were euthanized with an injection of pentobarbital sodium soon after stent placement. Immediately after cardiopulmonary arrest, the esophagus and trachea were removed from the chest cavity. Gross examinations were performed to evaluate the persistence of the esophagotracheal fistula and to confirm the seal by stent placement.
Experiment 2: Evaluating Stent Migration
To evaluate the efficacy of our method, we conducted the following experiment using three pigs. We used the original stents that were developed using a single thread of 0.165-mm nitinol wire in a tubular configuration and coated with polytetrafluoroethylene. When fully expanded, the stents were 20 mm in diameter and 60-mm long. A string was tied to the proximal edge of the stent. These stents were specially made by S&G Bio Tech (Seoul, Korea; Fig. 1B ).
We created an esophagotracheal fistula using the same technique as applied in the first experiment. The snare wire was then introduced into the esophagus using a transcervical approach. After that, the introducer set was passed over the guidewire through the mouth until the distal tip of the set reached the thoracic esophagus. The stent was deployed to seal the fistula. The snare was drawn back and the string pulled outside of the body for suturing under the skin. Postprocedural fluoroscopy was performed immediately after stent placement to verify stent position. Esophagography was performed to ensure that no nonionic contrast medium was leaking into the trachea.
The three pigs were given liquid food to prevent food impaction during the follow-up period after stent placement. The pigs were then scheduled to be euthanized at 11 days (n = 2) or 12 days (n = 1) after stent placement. Esophagography using nonionic contrast medium was performed before sacrifice to verify the position of the stent and evaluate stent migration. Gross examination was A An RFB filled with nonionic contrast medium (arrow) is punctured by percutaneous approach. B The RFB and second guidewire are advanced downward simultaneously into the distal esophagus. The guidewire is then introduced into the esophageal lumen. C The first guidewire from the mouth is advanced downward into the distal esophagus through a loop snare introduced by transcervical approach. D A sheath with a dilator is introduced over the guidewire through the mouth until the distal tip reaches the thoracic esophagus. The handmade stent is then compressed until it fits into the distal end of the sheath. E The stent is deployed to seal the esophagotracheal fistula. F The string (arrow) is pulled out of the body by the loop snare and sutured under the skin of the neck performed to check the fistula, tissue hyperplasia, and esophageal injuries, such as perforation or inflammation. Tissue samples were fixed in 10% formalin solution for microscopic examination. Specimens underwent standard histological processing, were stained with hematoxylin and eosin, and were evaluated under light microscopy.
Results
In all cases of both experiments, an esophagotracheal fistula was established without any complications. Access to the trachea was completed within two punctures in all cases. Esophagograms showed leakage of nonionic contrast medium from the esophagus into the trachea through the created fistula. All animals received covered SEMS that we had prepared, with the string sutured under the skin of the neck during the same procedure. All stents were placed in the intended position initially. We did not encounter any technical difficulties with the deployment mechanism. Esophagograms after stent placement showed the created fistula was sealed in all cases.
In the first experiment, gross findings in all pigs showed patent esophagotracheal fistula that was sealed by stent placement. In the second experiment, we did not find clinical signs of aspiration pneumonia during follow-up in any pig. Radiographic assessment before sacrifice showed full stent patency and no stent migration (Fig. 4) . Gross findings showed adhesion between the esophagus and trachea at the site of the created fistula. No fistulas were identified on the esophageal or tracheal wall in three pigs. Abscess formation was not found under the skin of the neck at the point of string fixation or in the mediastinum. One pig showed an induration at the site of puncture in the tracheal wall. Mild tissue hyperplasia was seen at the point where the stent ends contacted with the tissue in all pigs. Microscopic findings demonstrated epithelial hyperplasia and proliferation of submucosal granulation tissue (Fig. 5) . Ruptured tracheal cartilages were seen at the site of induration.
Discussion
SEMS are now being used with increasing frequency for malignant dysphagia, esophagotracheal fistula [13, 14] corrosive burn injury [15] , spontaneous perforation [16] [17] [18] , iatrogenic injuries [19] , and anastomotic leaks [20] [21] [22] [23] [24] [25] [26] [27] . Some investigators have attempted to control variceal bleeding with traditional removable SEMS and with a covered stent modified with an inflatable cardia balloon [28] . Although SEMS has been widely used for several such diseases, past results have been unsatisfactory. One of the most major drawbacks of SEMS is the risk of stent migration. Stent migration often causes not only recurrent dysphagia due to restenosis but also aspiration pneumonia and mediastinitis due to patency of fistula or anastomotic leak.
The migration rate for uncovered SEMS is less than 5% [29] compared with 10-35% for covered SEMS [30] . Furthermore, the rate of stent migration is likely to be higher in patients without strictures [12] or when the lower end of the stent projects into the fundus of the stomach [31] . With uncovered stents, the esophageal mucosa or tumor are seen to project slightly into the stent lumen. This projection into the stent provides a defense against migration that is not available with covered SEMS. In addition, the reduced friction between the stent membrane and esophageal wall encourages migration of covered SEMS.
Several methods to prevent stent migration have been reported. Some authors have tried to fix the stent using endoclips [32] , but inserting the clips between the metallic mesh may be not possible if the stent is totally covered. Moreover, clips can only be applied to parts of the esophageal wall if the esophagus is dilated, often precluding fistula closure. Another method using a polypectomy snare has been reported [12] , but it has a main disadvantage of nasopharyngeal discomfort. Barbs have been used to prevent esophageal stent migration [33] , but they need to be short enough to avoid causing perforation of adjacent organs. Although some new stents with antimigration properties have been developed [34, 35] , the problem with migration has not been completely resolved. In addition, stent migration is said to be decreased in cases of large stent diameter because of greater radial force [36] . However, large-diameter stents seem to be associated with more complications, such as thoracic pain and perforation involving the esophagus, than small-diameter stents and therefore are not frequently used [37, 38] .
This preliminary study revealed that our new hangingtype stent overcame distal stent migration and successfully treated esophagotracheal fistula without technical difficulties, even though the pigs had no stricture. Our new stent almost completely prevents distal stent migration, because the stent is fixed in place by a string and does not require uncomfortable methods, such as fixation outside of the body. Although this study was performed for an animal model of esophagotracheal fistula, the method seems to be applicable to several esophageal disorders and permits placement of the stent anywhere, including the esophagogastric junction, a site at which stent migration often occurs. In addition, our new stent does not need a large stent diameter, avoiding the increased risk of complications.
The problem with our stent is that proximal migration is not prevented. However, in many cases, proximal migration is less serious than distal migration. Distal migration may necessitate extraction of the stent surgically if the patient experiences pain, whereas proximal migration is easily corrected by use of an additional stent or replacement [31] .
Another possibility is that fixing the string under the skin of the neck and associated pulling sensations may cause discomfort or pain to the patient. This potential problem needs to be addressed in clinical practice.
Mild tissue hyperplasia was shown at both ends of the stent after follow-up in Experiment 2. The tissue reaction seen in this study with the SEMS is consistent with previous reports in an animal model where a Wallstent was used to treat tracheoesophageal fistula [39] . Tissue hyperplasia secondary to stent placement adversely affects longterm patency and frequently makes stent removal difficult, thus requiring stent replacement or even surgical removal [40] . Further modification of esophageal stents will be necessary.
This study has several limitations. First, the number of pigs used was rather small. Second, we did not arrange control groups such that underwent stenting without string fixation in Experiment 2. We therefore could not confirm that stent migration would occur without the string. However, numerous studies have examined stent migration and methods of preventing migration. Wagner et al. reported distal stent migration in 5 of 12 pigs within the first 2 weeks in an experiment using pigs with esophagotracheal fistula [39] . Stent migration probably emerges at a high rate when using SEMS without the string. Third, we could not prove whether stents really encourage healing of esophagotracheal fistula, because we did not conduct comparisons with a control group lacking stents. However, many reports have described SEMS as useful to treat esophagotracheal fistula [1, [6] [7] [8] [9] [10] [11] . We thus think that our stents helped to treat fistula. Fourth, we performed evaluations after only 11 or 12 days in Experiment 2. More longterm assessments will be needed in the future.
In conclusion, our new hanging-type esophageal stent was designed to prevent stent migration appears to offer a feasible treatment option, particularly in the absence of esophageal stenosis where the likelihood of stent dislocation is very high. Further examination of this issue is warranted.
